Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4777016
Max Phase: Preclinical
Molecular Formula: C30H26F5N3O5S
Molecular Weight: 635.61
Molecule Type: Unknown
Associated Items:
ID: ALA4777016
Max Phase: Preclinical
Molecular Formula: C30H26F5N3O5S
Molecular Weight: 635.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1OCc2cc(N(Cc3ccc(C4CCCCC4)cn3)C(=O)[C@H]3CCN3S(=O)(=O)c3c(F)c(F)c(F)c(F)c3F)ccc21
Standard InChI: InChI=1S/C30H26F5N3O5S/c31-23-24(32)26(34)28(27(35)25(23)33)44(41,42)38-11-10-22(38)29(39)37(20-8-9-21-18(12-20)15-43-30(21)40)14-19-7-6-17(13-36-19)16-4-2-1-3-5-16/h6-9,12-13,16,22H,1-5,10-11,14-15H2/t22-/m1/s1
Standard InChI Key: RXYPIDNOZHMWNS-JOCHJYFZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 635.61 | Molecular Weight (Monoisotopic): 635.1513 | AlogP: 5.49 | #Rotatable Bonds: 7 |
Polar Surface Area: 96.88 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.82 | CX Basic pKa: 4.50 | CX LogP: 4.87 | CX LogD: 4.87 |
Aromatic Rings: 3 | Heavy Atoms: 44 | QED Weighted: 0.15 | Np Likeness Score: -0.87 |
1. Brotherton-Pleiss C,Yue P,Zhu Y,Nakamura K,Chen W,Fu W,Kubota C,Chen J,Alonso-Valenteen F,Mikhael S,Medina-Kauwe L,Tius MA,Lopez-Tapia F,Turkson J. (2021) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors., 64 (1.0): [PMID:33352047] [10.1021/acs.jmedchem.0c01705] |
Source(1):